Arid1a-deficient ovarian cancer cells have been shown to exhibit altered gene expression patterns, dysregulated cell cycle progression, impaired DNA damage repair, and an enhanced EMT phenotype. The gene discussed is ARID1A; the disease is ovarian carcinoma.